Why does immunosuppression increase the risk of aplastic anemia following exposure to parvovirus B19?

💡 Explanation

Immunosuppression increases the risk of aplastic anemia because it impairs the body’s ability to clear parvovirus B19, therefore increasing the duration and severity of erythroid progenitor infection. The persistent infection leads to sustained suppression of erythropoiesis, rather than a transient issue in immunocompetent individuals.

• What distinguishes the urea cycle in the liver from the Cori cycle during prolonged starvation?
• If a 55-year-old patient experiences progressively worsening blurred vision at close range despite wearing glasses, what distinguishes the mechanism causing this from simple refractive error?
• Why does two-point discrimination acuity vary across the skin surface?
• If a patient undergoing physical therapy reports increased pain despite tissue healing based on MRI evidence, which mechanism explains this amplified pain perception?
• In an elderly patient experiencing significant muscle loss (sarcopenia) despite adequate caloric intake, what distinguishes the underlying metabolic mechanism from simple protein malnutrition?
• If a patient with rheumatoid arthritis experiences increased joint inflammation despite NSAID treatment, which consequence follows from elevated intra-articular cytokine levels?